Unpacking Key Data in Chronic Myeloid Leukemia After ASH 2024 - Episode 2

Factors That Influence Treatment Decisions in Later-Line CML

,

Javier Pinilla, MD, PhD, and Talha Badar, MBBS, MD, discuss factors that influence later-line treatment choices in chronic myeloid leukemia.

EP. 1: Implications of the FDA Approval of Asciminib for Newly Diagnosed, Ph+ CP-CML
Now Viewing
EP. 2: Factors That Influence Treatment Decisions in Later-Line CML